Ghosh, R., Narasanna, A., Wang, S. E., Liu, S., Chakrabarty, A., Balko, J. M., . . . Arteaga, C. L. (2011). Trastuzumab has preferential activity against breast cancers driven by HER2 homodimers.
Citación estilo ChicagoGhosh, Ritwik, et al. Trastuzumab Has Preferential Activity against Breast Cancers Driven By HER2 Homodimers. 2011.
Cita MLAGhosh, Ritwik, et al. Trastuzumab Has Preferential Activity against Breast Cancers Driven By HER2 Homodimers. 2011.
Precaución: Estas citas no son 100% exactas.